Global burden of COPD: risk factors, prevalence, and future trends
暂无分享,去创建一个
[1] D. Tashkin. Smoked marijuana as a cause of lung injury. , 2005, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.
[2] Dean T. Jamison,et al. Measuring the Global Burden of Disease and Risk Factors, 1990–2001 , 2006 .
[3] R. Luben,et al. Area deprivation predicts lung function independently of education and social class , 2004, European Respiratory Journal.
[4] A. Agustí. Systemic effects of chronic obstructive pulmonary disease. , 2001, Novartis Foundation symposium.
[5] D. Sherrill,et al. Heavy habitual marijuana smoking does not cause an accelerated decline in FEV1 with age. , 1997, American journal of respiratory and critical care medicine.
[6] T L Petty,et al. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. , 2000, Archives of internal medicine.
[7] Third Expert Panel on theDiagnosis,et al. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma , 1997 .
[8] C. Fletcher. The Natural history of chronic bronchitis and emphysema: An eight-year study of early chronic obstructive lung disease in working men in London , 1976 .
[9] S. Hurd,et al. Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update , 2003, European Respiratory Journal.
[10] T. Płusa. [Epidemiology of chronic obstructive pulmonary disease]. , 2004, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.
[11] Steven Piantadosi,et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. , 2003, The New England journal of medicine.
[12] M. Miravitlles,et al. [Costs of chronic obstructive pulmonary disease in Spain. Estimation from a population-based study]. , 2004, Archivos de bronconeumologia.
[13] W. Bailey,et al. Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1 , 1994 .
[14] T. Seemungal,et al. COPD exacerbations: defining their cause and prevention , 2007, The Lancet.
[15] K Larsson,et al. Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies. , 2003, Respiratory medicine.
[16] M. Malesker,et al. Pharmacoeconomic evaluation of COPD. , 2000, Chest.
[17] J. Izquierdo,et al. The burden of COPD in Spain: results from the Confronting COPD survey. , 2003, Respiratory medicine.
[18] Judith K Jones,et al. Chronic obstructive pulmonary disease severity and cardiovascular outcomes , 2006, European Journal of Epidemiology.
[19] S. Rennard,et al. What have we learned from large drug treatment trials in COPD? , 2007, The Lancet.
[20] Ramon Gisbert,et al. Costs of chronic bronchitis and COPD: a 1-year follow-up study. , 2003, Chest.
[21] Lung. Chronic obstructive pulmonary disease , 1981 .
[22] I. Adcock,et al. Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase , 2004, The Lancet.
[23] D. Lawlor,et al. Association between self-reported childhood socioeconomic position and adult lung function: findings from the British Women’s Heart and Health Study , 2004, Thorax.
[24] Cesar G Victora,et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study , 2005, The Lancet.
[25] F. Raschke,et al. Usefulness of GOLD classification of COPD severity , 2003, Thorax.
[26] Ki Moon Bang,et al. Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination Survey. , 2002, American journal of epidemiology.
[27] N. Zhong,et al. [The risk factors for chronic obstructive pulmonary disease in females in Chinese rural areas]. , 2006, Zhonghua nei ke za zhi.
[28] N. Anthonisen. The British hypothesis revisited , 2004, European Respiratory Journal.
[29] G. Davey Smith,et al. The natural history of chronic obstructive pulmonary disease , 2006, European Respiratory Journal.
[30] R. West,et al. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample , 2006, Thorax.
[31] F. Blasi,et al. Anxiety and depression in COPD patients: The roles of gender and disease severity. , 2006, Respiratory medicine.
[32] B. Celli,et al. Gender and COPD in patients attending a pulmonary clinic. , 2006, Chest.
[33] Fernando Holguin,et al. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. , 2005, Chest.
[34] M. Decramer,et al. Systemic effects of COPD. , 2005, Respiratory medicine.
[35] P. Calverley,et al. Chronic obstructive pulmonary disease , 2003, The Lancet.
[36] Ciro Casanova,et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.
[37] J. Vestbo,et al. COPD: the dangerous underestimate of 15% , 2006, The Lancet.
[38] D. Górecka,et al. Smokers with airway obstruction are more likely to quit smoking , 2006, Thorax.
[39] R. Vermeulen,et al. Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers , 2006, Thorax.
[40] D. Mannino,et al. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study , 2007, The Lancet.
[41] D. Mannino,et al. Lung function decline and outcomes in an elderly population , 2005, Thorax.
[42] K. R. Chapman,et al. Epidemiology and costs of chronic obstructive pulmonary disease , 2006, European Respiratory Journal.
[43] Joseph Menzin,et al. Assessment of the Economic Burden of COPD in the U.S.: A Review and Synthesis of the Literature , 2006, COPD.
[44] Ramon Gisbert,et al. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. , 2002, Chest.
[45] W. MacNee,et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.
[46] D. Mannino,et al. Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. , 2002, Morbidity and mortality weekly report. Surveillance summaries.
[47] J. Hogg,et al. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease , 2004, The Lancet.
[48] R. Pauwels,et al. Burden and clinical features of chronic obstructive pulmonary disease (COPD) , 2004, The Lancet.
[49] L. Trupin,et al. The occupational burden of chronic obstructive pulmonary disease , 2003, European Respiratory Journal.
[50] Joan B Soriano,et al. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. , 2003, Chest.
[51] M. Nishimura,et al. COPD in Japan: the Nippon COPD Epidemiology study , 2004, Respirology.
[52] N. Anthonisen,et al. Mortality in COPD: role of comorbidities , 2006, European Respiratory Journal.
[53] E. Wagner. Chronic disease care , 2004, BMJ : British Medical Journal.
[54] Ramon Gisbert,et al. Clinical InvestigationsBronchitisCosts of Chronic Bronchitis and COPDa: A 1-Year Follow-up Study , 2003 .
[55] G. Little,et al. The natural history of chronic bronchitis and emphysema , 1979 .
[56] D. Mannino,et al. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. , 2006, Respiratory medicine.
[57] Alan D. Lopez,et al. Global burden of disease and risk factors , 2006 .
[58] N. Anthonisen,et al. Use of spirometry and respiratory drugs in Manitobans over 35 years of age with obstructive lung diseases. , 2005, Canadian respiratory journal.
[59] S. Hashimoto,et al. Incidence of Chronic Obstructive Pulmonary Disease, and the Relationship between Age and Smoking in a Japanese Population , 2007, Journal of epidemiology.
[60] K. Morgan,et al. A polymorphism in the tumor necrosis factor-alpha gene promoter region may predispose to a poor prognosis in COPD. , 2000, Chest.
[61] N. Anthonisen. Chronic obstructive pulmonary disease. , 1988, Canadian respiratory journal.
[62] E. Silverman,et al. Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.
[63] P. Barnes,et al. Chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.
[64] P. Enright,et al. Clinical bronchiolitis obliterans in workers at a microwave-popcorn plant. , 2002, The New England journal of medicine.
[65] G. Snider. Nosology for our day: its application to chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.
[66] A. Jemal,et al. Trends in the leading causes of death in the United States, 1970-2002. , 2005, JAMA.
[67] R. Rodríguez-Roisín,et al. Improving the care of COPD patients - suggested action points by the COPD exacerbations taskforce for reducing the burden of exacerbations of COPD. , 2006, Primary care respiratory journal : journal of the General Practice Airways Group.
[68] T. Seemungal,et al. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.
[69] C. D. Mathers,et al. Chronic obstructive pulmonary disease: current burden and future projections , 2006, European Respiratory Journal.
[70] E H Wagner,et al. Chronic disease management: what will it take to improve care for chronic illness? , 1998, Effective clinical practice : ECP.
[71] W. Bailey,et al. Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: an NHLBI workshop report. , 2006, American journal of respiratory and critical care medicine.
[72] J Vestbo,et al. A 15-year follow-up study of ventilatory function in adults with asthma. , 1998, The New England journal of medicine.
[73] S. Uh,et al. Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. , 2005, American journal of respiratory and critical care medicine.
[74] J. Vestbo,et al. Update on the "Dutch hypothesis" for chronic respiratory disease , 1998, Thorax.
[75] M. Miravitlles,et al. Costes de la EPOC en España. Estimación a partir de un estudio epidemiológico poblacional , 2004 .
[76] W. MacNee,et al. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. , 2005, Proceedings of the American Thoracic Society.
[77] Kiros Berhane,et al. Effects of glutathione S-transferase M1, maternal smoking during pregnancy, and environmental tobacco smoke on asthma and wheezing in children. , 2002, American journal of respiratory and critical care medicine.
[78] T. Seemungal,et al. COPD exacerbations: defi ning their cause and prevention , 2007 .
[79] S. Johnston,et al. Mechanisms and experimental models of chronic obstructive pulmonary disease exacerbations. , 2005, Proceedings of the American Thoracic Society.
[80] A. Gulsvik,et al. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study , 2005, Thorax.
[81] A. Iqbal,et al. Interpreting COPD prevalence estimates: what is the true burden of disease? , 2003, Chest.
[82] D. Mannino,et al. Global burden of COPD: systematic review and meta-analysis , 2006, European Respiratory Journal.
[83] James K Stoller,et al. α1-antitrypsin deficiency , 2005, The Lancet.
[84] N. Laird,et al. The transforming growth factor-beta1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD). , 2004, Human molecular genetics.
[85] Scott T. Weiss,et al. The transforming growth factor-β1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD) , 2004 .
[86] P. Yang,et al. Genetic polymorphism of epoxide hydrolase and glutathione S-transferase in COPD , 2004, European Respiratory Journal.
[87] K. Kimm,et al. The local prevalence of COPD by post-bronchodilator GOLD criteria in Korea. , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[88] S. Rennard. COPD: overview of definitions, epidemiology, and factors influencing its development. , 1998, Chest.